Allyson Kinzel named senior vice president and chief legal officer at MD Anderson

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MD Anderson Cancer Center has named Allyson Hancock Kinzel as senior vice president and chief legal officer, effective Nov. 1.

Kinzel will lead legal and regulatory affairs in her role after serving as chief legal officer since 2018. She will report to the president and will be a member of the institution’s executive leadership team.

As senior vice president, Kinzel will oversee three legal and regulatory departments: Legal Services, Internal Audit and the Office of Institutional Compliance. Kinzel will be responsible for identifying and managing risk across the institution, leading auditing and monitoring efforts and ensuring the institution’s compliance with federal and state laws. As chief legal officer, she has guided responses to hospital-wide federal regulatory surveys, established MD Anderson’s institutional conflict of interest policy and program structure and led the institution’s response to the Office for Civil Rights regarding federal enforcement provisions.

Before serving as chief legal officer, Kinzel worked for 10 years in Institutional Compliance at MD Anderson and was vice president and chief compliance and ethics officer from 2014 to 2018. Prior to coming to MD Anderson, Kinzel represented health care providers as a partner at Baker Hostetler, LLP, and as an attorney at Vinson and Elkins, LLP.

YOU MAY BE INTERESTED IN

The long-awaited results from the RASolute 302 trial—a phase III clinical trial evaluating daraxonrasib, a RAS inhibitor, for the treatment of patients with previously treated, metastatic pancreatic ductal adenocarcinoma—have been read out. 
At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login